IGHE and allergic asthma: Serum IgE levels have been used to determine the amount of omalizumab to be given to patients with severe allergic asthma for optimal response,30 while blood eosinophil counts have been used as a biomarker to choose those with the greatest likelihood of responding to benralizumab.16